DK3717476T3 - Fremgangsmåde til fremstilling af 2-(5-methoxyisochroman-1-yl)-4,5-dihydro-1H-imidazol og hydrogensulfatsaltet deraf - Google Patents
Fremgangsmåde til fremstilling af 2-(5-methoxyisochroman-1-yl)-4,5-dihydro-1H-imidazol og hydrogensulfatsaltet deraf Download PDFInfo
- Publication number
- DK3717476T3 DK3717476T3 DK18822414.1T DK18822414T DK3717476T3 DK 3717476 T3 DK3717476 T3 DK 3717476T3 DK 18822414 T DK18822414 T DK 18822414T DK 3717476 T3 DK3717476 T3 DK 3717476T3
- Authority
- DK
- Denmark
- Prior art keywords
- methoxyisochroman
- dihydro
- imidazole
- preparation
- hydrogen sulfate
- Prior art date
Links
- GHIKYGQWBRHEGU-UHFFFAOYSA-N 2-(5-methoxy-3,4-dihydro-1h-isochromen-1-yl)-4,5-dihydro-1h-imidazole Chemical compound O1CCC=2C(OC)=CC=CC=2C1C1=NCCN1 GHIKYGQWBRHEGU-UHFFFAOYSA-N 0.000 title 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical class OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/76—Benzo[c]pyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Epoxy Resins (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20176085 | 2017-12-01 | ||
| PCT/FI2018/050864 WO2019106238A1 (en) | 2017-12-01 | 2018-11-30 | Process for the preparation of 2-(5-methoxyisochroman-1 -yl)-4,5-dihydro-1 h-imidazole and the hydrogensulfate salt thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3717476T3 true DK3717476T3 (da) | 2022-09-05 |
Family
ID=64746580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18822414.1T DK3717476T3 (da) | 2017-12-01 | 2018-11-30 | Fremgangsmåde til fremstilling af 2-(5-methoxyisochroman-1-yl)-4,5-dihydro-1H-imidazol og hydrogensulfatsaltet deraf |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US11352346B2 (da) |
| EP (1) | EP3717476B1 (da) |
| JP (1) | JP7339946B2 (da) |
| KR (1) | KR102718536B1 (da) |
| CN (1) | CN111630049B (da) |
| AU (1) | AU2018376872B2 (da) |
| BR (1) | BR112020010617A2 (da) |
| CA (1) | CA3083734A1 (da) |
| DK (1) | DK3717476T3 (da) |
| ES (1) | ES2927193T3 (da) |
| HR (1) | HRP20221247T1 (da) |
| HU (1) | HUE059849T2 (da) |
| IL (1) | IL274931B2 (da) |
| LT (1) | LT3717476T (da) |
| PL (1) | PL3717476T3 (da) |
| PT (1) | PT3717476T (da) |
| SI (1) | SI3717476T1 (da) |
| WO (1) | WO2019106238A1 (da) |
| ZA (1) | ZA202003981B (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021020935A1 (ko) | 2019-07-31 | 2021-02-04 | 현대자동차주식회사 | 차량 내부 네트워크에 대한 sdn 기반의 침입 대응 방법 및 이를 이용한 시스템 |
| AU2022236605A1 (en) * | 2021-03-19 | 2023-11-02 | Orion Corporation | Tasipimidine formulations and use thereof |
| JP2025502480A (ja) | 2022-01-24 | 2025-01-24 | オリオン コーポレーション | イソクロマン－イミダゾール構造のアルファ－２ａアドレナリン受容体アゴニストの新規な硫酸塩形 |
| AU2023215667A1 (en) | 2022-02-04 | 2024-09-12 | Orion Corporation | Novel salt forms of isochroman-imidazole structured alpha-2a adrenoceptor agonist |
| JP2025531623A (ja) | 2022-09-28 | 2025-09-22 | オリオン コーポレーション | タシピミジンおよびｃｙｐ２ｄ６阻害薬の併用療法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6410562B1 (en) * | 1998-12-18 | 2002-06-25 | Eli Lilly And Company | Hypoglycemic imidazoline compounds |
| AR090557A1 (es) * | 2012-04-02 | 2014-11-19 | Orion Corp | DERIVADOS IMIDAZOLICOS AGONISTAS ADRENERGICOS a2 |
-
2018
- 2018-11-30 KR KR1020207019100A patent/KR102718536B1/ko active Active
- 2018-11-30 AU AU2018376872A patent/AU2018376872B2/en active Active
- 2018-11-30 EP EP18822414.1A patent/EP3717476B1/en active Active
- 2018-11-30 PT PT188224141T patent/PT3717476T/pt unknown
- 2018-11-30 HR HRP20221247TT patent/HRP20221247T1/hr unknown
- 2018-11-30 PL PL18822414.1T patent/PL3717476T3/pl unknown
- 2018-11-30 ES ES18822414T patent/ES2927193T3/es active Active
- 2018-11-30 BR BR112020010617-8A patent/BR112020010617A2/pt unknown
- 2018-11-30 CA CA3083734A patent/CA3083734A1/en active Pending
- 2018-11-30 DK DK18822414.1T patent/DK3717476T3/da active
- 2018-11-30 HU HUE18822414A patent/HUE059849T2/hu unknown
- 2018-11-30 CN CN201880076883.0A patent/CN111630049B/zh active Active
- 2018-11-30 WO PCT/FI2018/050864 patent/WO2019106238A1/en not_active Ceased
- 2018-11-30 US US16/768,093 patent/US11352346B2/en active Active
- 2018-11-30 JP JP2020529522A patent/JP7339946B2/ja active Active
- 2018-11-30 IL IL274931A patent/IL274931B2/en unknown
- 2018-11-30 SI SI201830738T patent/SI3717476T1/sl unknown
- 2018-11-30 LT LTEPPCT/FI2018/050864T patent/LT3717476T/lt unknown
-
2020
- 2020-06-30 ZA ZA2020/03981A patent/ZA202003981B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL274931B2 (en) | 2023-11-01 |
| US20200308152A1 (en) | 2020-10-01 |
| RU2020121597A (ru) | 2022-01-04 |
| HRP20221247T1 (hr) | 2022-12-09 |
| WO2019106238A1 (en) | 2019-06-06 |
| CN111630049B (zh) | 2023-06-20 |
| BR112020010617A2 (pt) | 2020-11-10 |
| IL274931A (en) | 2020-07-30 |
| HUE059849T2 (hu) | 2023-01-28 |
| AU2018376872A1 (en) | 2020-07-16 |
| RU2020121597A3 (da) | 2022-01-04 |
| CN111630049A (zh) | 2020-09-04 |
| EP3717476A1 (en) | 2020-10-07 |
| JP7339946B2 (ja) | 2023-09-06 |
| KR20200095519A (ko) | 2020-08-10 |
| US11352346B2 (en) | 2022-06-07 |
| SI3717476T1 (sl) | 2022-10-28 |
| LT3717476T (lt) | 2022-09-26 |
| AU2018376872B2 (en) | 2023-12-07 |
| IL274931B1 (en) | 2023-07-01 |
| JP2021504418A (ja) | 2021-02-15 |
| ZA202003981B (en) | 2021-07-28 |
| ES2927193T3 (es) | 2022-11-03 |
| PL3717476T3 (pl) | 2022-11-21 |
| KR102718536B1 (ko) | 2024-10-21 |
| PT3717476T (pt) | 2022-08-23 |
| CA3083734A1 (en) | 2019-06-06 |
| EP3717476B1 (en) | 2022-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3286181T3 (da) | Pyrazolforbindelser og fremgangsmåde til fremstilling og anvendelse af forbindelserne | |
| DK3376859T3 (da) | Mikroorganismer til fremstilling af insektferomoner og relaterede forbindelser | |
| DK3491173T3 (da) | Fremgangsmåde og anlæg til fremstilling af methanol | |
| DK3283136T4 (da) | Hydrofile belægninger og fremgangsmåder til dannelse af samme | |
| DK3606760T3 (da) | Indretning og fremgangsmåde til belægning af overflader | |
| DK3578547T3 (da) | Sulfonylureaer og relaterede forbindelser og brug af samme | |
| DK3668851T3 (da) | Fremgangsmåde til fremstilling af thiocarbonater | |
| DK3497081T3 (da) | Fremgangsmåde til fremstilling af 4-ammonium-2,2,6,6-tetraalkylpiperidinylsalte | |
| DK3717476T3 (da) | Fremgangsmåde til fremstilling af 2-(5-methoxyisochroman-1-yl)-4,5-dihydro-1H-imidazol og hydrogensulfatsaltet deraf | |
| DK3488028T3 (da) | Fremgangsmåde til elektrokemisk fremstilling af ammoniak | |
| DK3355329T3 (da) | Metode til fremstilling af lithium-ion-kondensator og kondensator som opnås med den nævnte metode | |
| DK3515832T3 (da) | Spunstromle med inderbeholder, inderbeholder og fremgangsmåde til fremstilling af spunstromlen | |
| DK4434585T3 (da) | Forbindelser og fremgangsmåder til reduktion af snca-ekspression | |
| DK3678648T3 (da) | Fremgangsmåder til anvendelse af dipivefrin | |
| DK3429998T3 (da) | Fremgangsmåde til fremstilling af quinolin-2-yl-phenylaminderivater og disses salte | |
| DK3307675T3 (da) | Multi-tryk-fremgangsmåde til fremstilling af ammoniak | |
| DK3275883T3 (da) | Fremgangsmåde til produktion af ny nitrogenholdig forbindelse eller salt deraf, og mellemprodukt deraf | |
| DK3710000T3 (da) | Tradipitant til anvendelse til behandling af gastroparese | |
| DK3279202T3 (da) | Krystal af 3,5-disubstitueret benzenalkynylforbindelse | |
| DK3347342T3 (da) | Fremgangsmåde til fremstilling af biguanidin-salte og s-triaziner | |
| DK3412671T3 (da) | TLR7-agonist-maleatsalt, krystallinske former C, D og E deraf, fremgangsmåder til fremstilling og anvendelser af maleatsalt og krystallinske former | |
| DK3684813T3 (da) | Agonistiske cd40-antistoffer | |
| DK3255046T3 (da) | Hydroxyethylsulfonat af cyclin-afhængig proteinkinasehæmmer, krystallinsk form deraf og fremgangsmåde til fremstilling deraf | |
| DK3458448T3 (da) | Fasn-inhibitorer til anvendelse til behandling af non-alkoholisk steatohepatitis | |
| DK3265443T3 (da) | Pyrrolidincarboxamidderivater og fremgangsmåde til fremstilling og anvendelse af samme |